BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 4999308)

  • 1. Preventing maternal sensitization to Rho antigen.
    Alter AA; Haut IH
    N Y State J Med; 1971 Oct; 71(19):2326-7. PubMed ID: 4999308
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current trends in immunoprophylaxis of anti-Rho isoimmunization].
    Sirchia G; Mercuriali F
    Clin Ter; 1970 Feb; 52(4):385-90. PubMed ID: 5005934
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention of RH sensitization in Switzerland].
    Bamelli GP
    Pathologica; 1972; 64(929):101-3. PubMed ID: 4210411
    [No Abstract]   [Full Text] [Related]  

  • 4. [Problem of the dose of immunoglobulins in the prevention of hemolytic disease of newborn due to materno-fetal incompatibility of antigen D, in case of massive feto-maternal hemorrhage].
    Mattone PG; Meriggi E; De Martin G
    Minerva Ginecol; 1972 May; 24(7):337-41. PubMed ID: 4211573
    [No Abstract]   [Full Text] [Related]  

  • 5. Rho-gam--anti-rho (D) immune globulin.
    Med Lett Drugs Ther; 1968 Nov; 10(23):94-5. PubMed ID: 4182834
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of IVIG in preventing exchange transfusions in Rh hemolytic disease.
    Aylin T; Berkan G
    Indian Pediatr; 2005 Jan; 42(1):77-9. PubMed ID: 15695869
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prevention of sensitization of Rh-negative mothers following birth of a Rh-positive child and blood group serological control of mothers during pregnancy].
    Schneider J; Preisler O
    Hippokrates; 1968 Mar; 39(5):165-70. PubMed ID: 4978254
    [No Abstract]   [Full Text] [Related]  

  • 8. Preventing RH hemolytic disease.
    Weinstein L
    Ariz Med; 1980 Jan; 37(1):28. PubMed ID: 6769421
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prevention of Rh-sensitization in primiparas by means of human anti-rhesus-Rho (D) immunoglobulin].
    Verbitskiĭ MSh; Bashlaĭ AG; Morgulis NB
    Vopr Okhr Materin Det; 1978 Jan; 23(1):27-8. PubMed ID: 415432
    [No Abstract]   [Full Text] [Related]  

  • 10. [Intravenous anti-D immunoglobulins. (Prevention of anti-Rh immunization in France)].
    Jouvenceaux A
    Pathologica; 1972; 64(929):91-9. PubMed ID: 4210233
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prevention and treatment of Rh. isoimmunization. Results].
    Martínez M; Lozano G; Flores F; Fernández P; Garrido G
    Acta Obstet Ginecol Hisp Lusit; 1971 Mar; 19(2):149-57. PubMed ID: 4996734
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of human anti-Rh(D) immunoglobulin].
    Novák J
    Cesk Pediatr; 1973 Nov; 28(11):627. PubMed ID: 4203640
    [No Abstract]   [Full Text] [Related]  

  • 13. [Passive antibody transfer into the parturient's blood after anti-D immunoglobulin administration for prevention of Rh sensitization].
    Merlak I; Mikulandra F; Kapitanović Z
    Lijec Vjesn; 1973 Jan; 95(1):11-3. PubMed ID: 4632047
    [No Abstract]   [Full Text] [Related]  

  • 14. Prophylaxis of maternal RH-sensitization by means of anti-D immunoglobulin.
    Petrov-Maslakov MA; Vasilyeva ZF; Matveyeva OF; Balasanyan IG; Sorina LI; Prigarnova TK
    Arch Immunol Ther Exp (Warsz); 1971; 19(3):343-8. PubMed ID: 4999474
    [No Abstract]   [Full Text] [Related]  

  • 15. [Selective Rh prevention in pregnancy].
    Helderweirt G
    Verh K Acad Geneeskd Belg; 1983; 45(3):261-74. PubMed ID: 6421025
    [No Abstract]   [Full Text] [Related]  

  • 16. [Indications for and efficacy of a low-dose of anti-D immunoglobulin].
    Bellati U; Morici A; Riccardi P; Serri FG; Garzetti GG
    Minerva Ginecol; 1977 Feb; 29(2):91-4. PubMed ID: 404598
    [No Abstract]   [Full Text] [Related]  

  • 17. [Preliminary clinical experiences with immunosuppressive agents in prenatal treatment of Rh isoimmunization].
    Viozzi A; Gasparini G; Cagliari P
    Minerva Ginecol; 1970 May; 22(9):462-3. PubMed ID: 4995416
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prospects of the clinical use of immunosuppressive agents in control of materno-fetal Rh isoimmunization and in attempted prevention. (Theoretical presuppositions and preliminary clinical experiences)].
    Vecchietti G; Onnis A
    Minerva Ginecol; 1970 May; 22(9):459-62. PubMed ID: 4995415
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of gamma globulin (anti-Rh IgG) in the prevention of Rh isoimmunization].
    Rosemblit J; Rosales T; de Lima GR; Leonhardt HG; Fonseca A; Martins H
    Matern Infanc (Sao Paulo); 1971; 30(1):41-4. PubMed ID: 5002691
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of the polyspecific properties of anti-D-immunoglobulin in preventing sensitization of the mother to various antigens in the blood of the fetus].
    Petrov-Maslakov MA; Vasil'eva Z; Shabalin VN
    Vopr Okhr Materin Det; 1972 May; 17(5):47-51. PubMed ID: 4623997
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.